Can repaglinide and linagliptin tablets be taken at the same time?

Repaglinide and linagliptin tablets should generally not be taken simultaneously, as this may lead to adverse effects. The detailed analysis is as follows:

Repaglinide is a clinically used oral hypoglycemic agent for the treatment of diabetes. It lowers blood glucose levels by stimulating insulin release from pancreatic beta cells. Linagliptin tablets increase the concentration of active incretin hormones and stimulate insulin release in a glucose-dependent manner, thereby reducing circulating glucagon levels. As such, both medications have similar mechanisms of action—promoting insulin secretion to lower blood glucose. If taken together, they may cause a significant drop in blood sugar levels and potentially induce hypoglycemia; therefore, concurrent use is generally not recommended.

After diagnosis of diabetes, patients are advised to actively seek standardized treatment under the guidance of an endocrinologist and make appropriate lifestyle adjustments to maintain blood glucose within normal ranges and prevent complications.